These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1595 related items for PubMed ID: 26269188

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development.
    Hong JY, Chen TH, Chen YJ, Liu CC, Jan JT, Wu SC.
    Antiviral Res; 2019 Apr; 164():12-22. PubMed ID: 30738089
    [Abstract] [Full Text] [Related]

  • 25. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM, Latham T, Cupo A.
    Viral Immunol; 2005 Apr; 18(2):365-72. PubMed ID: 16035948
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D, Cupo A, Galarza JM.
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [Abstract] [Full Text] [Related]

  • 29. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [Abstract] [Full Text] [Related]

  • 30. Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design.
    Liu WC, Liu YY, Chen TH, Liu CC, Jan JT, Wu SC.
    Antiviral Res; 2016 Sep; 133():110-8. PubMed ID: 27491439
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
    Ninomiya A, Imai M, Tashiro M, Odagiri T.
    Vaccine; 2007 May 04; 25(18):3554-60. PubMed ID: 17293015
    [Abstract] [Full Text] [Related]

  • 33. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
    Pyo HM, Masic A, Woldeab N, Embury-Hyatt C, Lin L, Shin YK, Song JY, Babiuk S, Zhou Y.
    Vaccine; 2012 Feb 08; 30(7):1297-304. PubMed ID: 22207090
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dual N-linked glycosylation at residues 133 and 158 in the hemagglutinin are essential for the efficacy of H7N9 avian influenza virus like particle vaccine in chickens and mice.
    Wang Y, Li Q, Peng P, Zhang Q, Huang Y, Hu J, Hu Z, Liu X.
    Vet Microbiol; 2024 Jul 08; 294():110108. PubMed ID: 38729093
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
    Even-Or O, Samira S, Rochlin E, Balasingam S, Mann AJ, Lambkin-Williams R, Spira J, Goldwaser I, Ellis R, Barenholz Y.
    Vaccine; 2010 Sep 07; 28(39):6527-41. PubMed ID: 20412874
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G, Song L, Reiserova L, Trivedi U, Li H, Liu X, Noah D, Hou F, Weaver B, Tussey L.
    Vaccine; 2012 Nov 06; 30(48):6833-8. PubMed ID: 23000130
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 80.